Previous 10 | Next 10 |
home / stock / ibrx / ibrx articles
Shares of Rocket Lab USA, Inc. (NASDAQ: RKLB) shares rose sharply in pre-market trading after the company announced a new $515 million contract wi...
U.S. stocks traded mixed, with the Dow Jones index falling around 50 points on Wednesday. Shares of The Toro Company (NYSE: TTC) rose sharply durin...
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Trane Technologies plc (NYSE: TT) so much. "I still like it,...
Gainers Miromatrix Medical Inc. (NASDAQ: MIRO) shares climbed 230.7% to $3.3401 after United Therapeutics agreed to acquire the company for $3.25...
U.S. stocks traded higher, with the Nasdaq Composite gaining more than 100 points on Monday. Here are some big stocks recording gains in today&rsqu...
Gainers Apollomics, Inc. (NASDAQ: APLM) shares surged 88.4% to $1.07 stoma multiforme with PTPRZ-MET fusion. BIO-key International, Inc. (NASDAQ...
U.S. stocks traded mixed, with the Nasdaq Composite gaining more than 100 points on Friday. Here are some big stocks recording gains in today&rsquo...
U.S. stock futures traded higher this morning on Friday. Here are some big stocks recording losses in today’s pre-market trading session. En...
Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares jumped 231.6% to $2.8190 after the company announced it entered into a term sheet to license t...
News, Short Squeeze, Breakout and More Instantly...
ImmunityBio Inc. Company Name:
IBRX Stock Symbol:
NASDAQ Market:
Multiple patients treated across the U.S. with ANKTIVA less than eight weeks after FDA approval of first-in-class cytokine immunotherapy for BCG unresponsive non-muscle invasive bladder cancer ANKTIVA launch initiates the next era of immunotherapy beyond checkpoint inhibitors that is based on...
2024-06-07 10:10:00 ET June 7, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform, releases the second of a two-part series looking at news and developments for the treatment of viruses, featuring Aethlon Medical, Inc. (Nasdaq: AEMD ), a medical the...
ImmunityBio, Inc. ( NASDAQ: IBRX ) announced today that its 2024 Annual Meeting of Stockholders will be held on Tuesday, June 11, 2024 at 9:30 a.m. Pacific Time. The Annual Meeting will be held in a virtual-only format and there will not be a physical location for the Annual Meeting. Stockhol...